Research Frontiers Reports Second Quarter 2026 Financial Results and Will Host a Conference Call at 4:30 p.m. Today

About this update from Research Frontiers Incorporated

WOODBURY, N.Y. , Aug. 06, 2026 (GLOBE NEWSWIRE) -- Research Frontiers Inc. (Nasdaq: REFR) announced its financial results for its second quarter of 2026. Management will host a conference call today at 4:30 p.m. Eastern Time to discuss its financial and operating results as well as recent developments.   • Who: Joseph M. Harary , President & CEO   • Date/Time: Thursday, August 6, 2026 , 4:30 PM ET   • Dial-in Information: 1-888-334-5785   • Conference Link: https://join.broaddata.com/?id=research-frontiers   • Replay: Available on Friday, August 7, 2026 for 90 days at https://smartglass-ir.com/ “The second quarter continued to reflect the temporary impact of our principal SPD-Smart light control film supplier's reduced production, rather than any change in the underlying demand for SPD-Smart technology," said Joseph M. Harary , President and CEO of Research Frontiers . "Throughout this period our customers remained committed, we added a new licensee, continued advancing new applications including black SPD technology, and maintained our strong intellectual property portfolio. While near-term financial results in the second quarter were affected by reduced SPD film production, we believe the resource-related issues at Gauzy is nearing its conclusion and we remain confident in the long-term opportunities for SPD technology.” Management expects during today’s conference call to discuss the status of developments at Gauzy including current SPD film production, and the Company's contingency plans to support future manufacturing capacity. For more details, please see the Company’s Quarterly Report on Form 10-Q for the fiscal quarter ending June 30, 2026 . About Research Frontiers Research Frontiers (Nasdaq: REFR) is a publicly traded technology company and the developer of patented SPD-Smart light-control film technology that allows users to instantly, precisely and uniformly control the shading of glass or plastic products, either manually or automatically. Research Frontiers has licensed its smart glass technology to numerous companies that include well known chemical, material science and glass companies. Products using Research Frontiers’ smart glass technology are being used in tens of thousands of cars, aircraft, yachts, trains, homes, offices, museums and other buildings. For more information, please visit our website at www.SmartGlass.com, and on Facebook, Twitter, LinkedIn and YouTube. Note: From time to time Research Frontiers may issue forward-looking statements which involve risks and uncertainties. This press release contains forward-looking statements. Actual results, especially those reliant on activities by third parties, could differ and are not guaranteed. Any forward-looking statements should be considered accordingly. “SPD-Smart” and “SPD-SmartGlass” are trademarks of Research Frontiers Inc. CONTACT: Joseph M. Harary President and CEO Research Frontiers Inc. +1-516-364-1902 [email protected] RESEARCH FRONTIERS INCORPORATED Condensed Consolidated Balance Sheets     June 30, 2026     December 31, 2025       (Unaudited)     (See Note 1)   Assets             Current assets:                 Cash and cash equivalents   $ 1,087,956     $ 664,299   Royalties receivable, net of reserves of $1,534,850 and $1,384,850 , respectively     207,955       408,666   Prepaid expenses and other current assets     159,730       70,969   Total current assets     1,455,641       1,143,934                     Fixed assets, net     2,867       3,393   Operating lease ROU assets     960,989       1,048,352   Deposits and other assets     56,066       56,066   Total assets   $ 2,475,563     $ 2,251,745                     Liabilities and Shareholders’ Equity                                   Current liabilities:                 Current portion of operating lease liability   $ 152,960     $ 146,043   Accounts payable     135,206       132,666   Deferred revenue     69,068       -   Accrued expenses     53,651       19,168   Total current liabilities     410,885       297,877                     Operating lease liability, net of current portion     941,585       1,020,242   Total liabilities     1,352,470       1,318,119                     Shareholders’ equity:                 Common stock, par value $0.0001 per share; authorized 100,000,000 shares, issued and outstanding 34,867,786 in 2026 and 33,648,221 in 2025     3,487       3,365   Additional paid-in capital     129,926,946       128,552,068   Accumulated deficit     (128,807,340 )     (127,621,807 ) Total shareholders’ equity     1,123,093       933,626                     Total liabilities and shareholders’ equity   $ 2,475,563     $ 2,251,745    RESEARCH FRONTIERS INCORPORATED Condensed Consolidated Statements of Operations (Unaudited)     Six months ended June 30 ,     Three months ended June 30 ,       2026     2025     2026     2025                             Fee income   $ 222,665     $ 689,680     $ 86,346     $ 129,904                                     Operating expenses     1,148,598       1,412,398       627,216       775,922   Research and development     274,234       331,963       128,884       169,086   Total expenses     1,422,832       1,744,361       756,100       945,008                                     Operating loss     (1,200,167 )     (1,054,681 )     (669,754 )     (815,104 )                                   Net interest income     14,634       25,811       9,586       11,278   Other income     -       47,357       -       -                                     Net loss   $ (1,185,533 )   $ (981,513 )   $ (660,168 )   $ (803,826 )                                   Basic and diluted net loss per common share   $ (0.03 )   $ (0.03 )   $ (0.02 )   $ (0.02 )                                   Weighted average number of common shares outstanding     34,513,740       33,648,221       34,867,786       33,648,221   RESEARCH FRONTIERS INCORPORATED Condensed Consolidated Statements of Shareholders’ Equity (Unaudited) For the six months ended June 30, 2025 and 2026     Common Stock     Additional Paid-in     Accumulated             Shares     Amount     Capital     Deficit     Total   Balance, January 1, 2025     33,648,221     $ 3,365     $ 128,177,193     $ (125,576,223 )   $ 2,604,335   Share-based compensation     -       -       175,204       -       175,204   Net loss     -       -       -       (981,513 )     (981,513 ) Balance, June 30, 2025     33,648,221     $ 3,365     $ 128,352,397     $ (126,557,736 )   $ 1,798,026                                             Balance, January 1, 2026     33,648,221     $ 3,365     $ 128,552,068     $ (127,621,807 )   $ 933,626   Issuance of common stock and warrants     1,219,565       122       1,374,878       -       1,375,000   Net loss     -       -       -       (1,185,533 )     (1,185,533 ) Balance, June 30, 2026     34,867,786     $ 3,487     $ 129,926,946     $ (128,807,340 )   $ 1,123,093   For the three months ended June 30, 2025 and 2026     Common Stock     Additional Paid-in     Accumulated             Shares     Amount     Capital     Deficit     Total   Balance, March 31, 2025     33,648,221     $ 3,365     $ 128,177,193     $ (125,753,910 )   $ 2,426,648   Share-based compensation     -       -       175,204       -       175,204   Net loss     -       -       -       (803,826 )     (803,826 ) Balance, June 30, 2025     33,648,221     $ 3,365     $ 128,352,397     $ (126,557,736 )   $ 1,798,026                                             Balance, March 31, 2026     34,867,786     $ 3,487     $ 129,926,946     $ (128,147,172 )   $ 1,783,261                                             Net loss     -       -       -       (660,168 )     (660,168 ) Balance, June 30, 2026     34,867,786     $ 3,487     $ 129,926,946     $ (128,807,340 )   $ 1,123,093   RESEARCH FRONTIERS INCORPORATED Condensed Consolidated Statements of Cash Flows (Unaudited)     Six months ended June 30 ,       2026     2025   Cash flows from operating activities:                 Net loss   $ (1,185,533 )   $ (981,513 ) Adjustments to reconcile net loss to net cash used in operating activities:                 Depreciation and amortization     631       6,166   Share-based compensation     -       175,204   Credit loss expense     150,000       124,253   ROU asset amortization     87,363       86,925   Change in assets and liabilities:                 Royalty receivables     50,711       (2,413 ) Prepaid expenses and other assets     (88,761 )     (67,791 ) Accounts payable and accrued expenses     37,023       (68,297 ) Deferred revenue     69,068       71,563   Operating lease liability     (71,740 )     (63,798 ) Net cash used in operating activities     (951,238 )     (719,701 )                   Cash flows from investing activities:                 Purchases of fixed assets     (105 )     (209 ) Net cash used in investing activities     (105 )     (209 )                   Cash flows from financing activities:                 Net proceeds from sale of common stock and warrants     1,375,000       -   Net cash provided by financing activities     1,375,000       -                     Net increase (decrease) in cash and cash equivalents     423,657       (719,910 )                   Cash and cash equivalents at beginning of period     664,299       1,994,186   Cash and cash equivalents at end of period   $ 1,087,956     $ 1,274,276   Source: Research Frontiers Incorporated 2026 GlobeNewswire, Inc., source Press Releases

View stock analysis, news, and events for Research Frontiers Incorporated